-Hindustan Times New Delhi: The Aam Aadmi Party (AAP) government has decided to deduct salaries of officials if they fail to provide services included in the citizen charter within the prescribed time limit. Previously, an applicant was allowed to claim compensation for delays but the government has proposed to make the process automatic and mandatory by amending the ‘Delhi (Right of Citizen to Time Bound Delivery of Services) Act 2011’. There are a...

-The Times of India NEW DELHI: Over 200 cancer drugs, 186 medicines to treat cardiovascular diseases and 148 stents and cardiac implants will now be available at central government hospitals at prices 50-60% lower than the open market. The health ministry has launched a programme called AMRIT (Affordable Medicines and Reliable Implants for Treatment), under which the government will run pharmacy retail stores to sell medicines in hospitals like All India Institute...

-Outlook New Delhi: One out of every five schools in the national capital does not have the periodic fire safety clearance CERTificate, according to a review conducted by the Delhi Fire Services which received the highest number of fire- related calls in the past 10 years this Diwali. "At least 20 per cent of the schools in the city – mostly the ones run by the government or municipal corporations – have...

-The Times of India NEW DELHI: Anti-cracker campaigns by the central and Delhi governments appeared to have made no significant impact as the capital celebrated another dirty Diwali, with fireworks well into the night, leaving the city's air choked with alarmingly high levels of pollution. Real time data showed levels of coarse pollution particles (PM 10) peak up to 19 times the national safe standard for 24 hours and levels of fine,...

-The Times of India NEW DELHI: In an attempt to ease norms for testing and introduction of new medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies planning to launch new drugs already approved outside India after conducting pre-clinical or toxicological studies on animals will not be required to repeat such studies in...